Drug Topics releases top 200 branded and generic drug lists
Despite a drop in the number of prescriptions written for the top 10 branded drugs in 2010 compared with 2009, there were gains in terms of retail dollars among most of the manufacturers of the top 10 products, according to the Drug Topics top 200 branded drugs lists.
The top 10 generic drugs in 2010 did well in terms of volume compared with the previous year, although this did not produce increased retail dollars for half of the top 10 generics, according to the Drug Topics top 200 generic drug lists.
To view the top 200 branded drugs list click here. For the top 200 generic drugs list, click here.
MORE ARTICLES IN THIS ISSUE
The battle against illegal drug promotion continues. The latest culprit is Novo Nordisk, which agreed to pay $25 million to settle civil liabilities over off-label promotion for its hemostasis drug NovoSeven (recombinant factor VIIa ) on June 10.
CDER recently announced that it will elevate the Office of Compliance to a Super Office to continue to ensure the safety, quality, and integrity of drugs in America, according to a memo from CDER Director Janet Woodcock.
Community pharmacists and medication therapy management can play a much greater role in Accountable Care Organizations, pharmacists? organizations said in new comments to the Centers for Medicare and Medicaid Services.